Pharmacokinetics of oral spironolactone in infants up to 2 years of age.
- Published in:
- European Journal of Clinical Pharmacology, 2024, v. 80, n. 2, p. 239, doi. 10.1007/s00228-023-03599-w
- By:
- Publication type:
- Article
Works matching IS 00316970 AND DT 2024 AND VI 80 AND IP 2
Results: 13
1
2
Correction to: Empagliflozin and colchicine in patients with reduced left ventricular ejection fraction following ST-elevation myocardial infarction: a randomized, double-blinded, three-arm parallel-group, controlled trial.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
3
Drug prescription profile in children with autism spectrum disorders.
- Published in:
- 2024
- By:
- Publication type:
- Letter
4
Safety analysis of therapeutic drugs for breast cancer patients and construction of a predictive model for serious adverse drug reactions.
- Published in:
- European Journal of Clinical Pharmacology, 2024, v. 80, n. 2, p. 249, doi. 10.1007/s00228-023-03604-2
- By:
- Publication type:
- Article
5
Physiologically based pharmacokinetic modeling of apixaban to predict exposure in populations with hepatic and renal impairment and elderly populations.
- Published in:
- European Journal of Clinical Pharmacology, 2024, v. 80, n. 2, p. 261, doi. 10.1007/s00228-023-03602-4
- By:
- Publication type:
- Article
6
The incidence and prevalence of proton pump inhibitor usage among internal medicine patients after hospital admission: A retrospective cohort study.
- Published in:
- European Journal of Clinical Pharmacology, 2024, v. 80, n. 2, p. 273, doi. 10.1007/s00228-023-03607-z
- By:
- Publication type:
- Article
7
A systematic review and meta-analysis of the efficacy of ketamine and esketamine on suicidal ideation in treatment-resistant depression.
- Published in:
- European Journal of Clinical Pharmacology, 2024, v. 80, n. 2, p. 287, doi. 10.1007/s00228-023-03605-1
- By:
- Publication type:
- Article
8
Challenges of pediatric pharmacotherapy: A narrative review of pharmacokinetics, pharmacodynamics, and pharmacogenetics.
- Published in:
- European Journal of Clinical Pharmacology, 2024, v. 80, n. 2, p. 203, doi. 10.1007/s00228-023-03598-x
- By:
- Publication type:
- Article
9
Antidepressant use and the risk of seizure: a meta-analysis of observational studies.
- Published in:
- European Journal of Clinical Pharmacology, 2024, v. 80, n. 2, p. 175, doi. 10.1007/s00228-023-03597-y
- By:
- Publication type:
- Article
10
Serotonin syndrome: A pharmacovigilance comparative study of drugs affecting serotonin levels.
- Published in:
- European Journal of Clinical Pharmacology, 2024, v. 80, n. 2, p. 231, doi. 10.1007/s00228-023-03596-z
- By:
- Publication type:
- Article
11
Association of antidepressants plus antithrombotics and bleeding risk: a pharmacovigilance study.
- Published in:
- European Journal of Clinical Pharmacology, 2024, v. 80, n. 2, p. 283, doi. 10.1007/s00228-023-03590-5
- By:
- Publication type:
- Article
12
Selective androgen receptor modulator use and related adverse events including drug-induced liver injury: Analysis of suspected cases.
- Published in:
- European Journal of Clinical Pharmacology, 2024, v. 80, n. 2, p. 185, doi. 10.1007/s00228-023-03592-3
- By:
- Publication type:
- Article
13
Effect of azilsartan on myocardial remodeling after acute myocardial infarction.
- Published in:
- European Journal of Clinical Pharmacology, 2024, v. 80, n. 2, p. 223, doi. 10.1007/s00228-023-03595-0
- By:
- Publication type:
- Article